Lexaria Bioscience Corp (LEXX)
1.08
+0.02
(+1.89%)
USD |
NASDAQ |
May 09, 16:00
1.08
0.00 (0.00%)
After-Hours: 20:00
Lexaria Bioscience Enterprise Value: 14.20M for May 9, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Aurinia Pharmaceuticals Inc | 734.70M |
| Edesa Biotech Inc | 13.78M |
| Xenon Pharmaceuticals Inc | 2.055B |
| ESSA Pharma Inc | -44.10M |
| ProMIS Neurosciences Inc | 3.086M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.713M |
| Revenue (Quarterly) | 0.174M |
| Total Expenses (Quarterly) | 2.925M |
| EPS Diluted (Quarterly) | -0.15 |
| Profit Margin (Quarterly) | -1.56K% |
| Earnings Yield | -54.63% |
| Normalized Earnings Yield | -54.50 |